Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.

  • Authors : Feng S; Institute of Uro‑Nephrology, Beijing Chao‑Yang Hospital, Capital Medical University, Beijing 100020, P.R. China.; Zhu X

Subjects: Cell Movement* ; Cell Proliferation* ; Gene Expression Regulation, Neoplastic*

  • Source: Molecular medicine reports [Mol Med Rep] 2016 May; Vol. 13 (5), pp. 4030-8. Date of Electronic Publication: 2016 Mar 21.Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.

  • Authors : Liu C; Department of Urology, Affiliated Zhongda Hospital of Southeast University, 87 Dingjia Bridge Hunan Road, Nanjing, 210009, China.; Surgical Research Center, Institute of Urology, Southeast University Medical School, 87 Dingjia Bridge Hunan Road, Nanjing, 210009, China.

Subjects: Cell Movement*; Epithelial-Mesenchymal Transition/Epithelial-Mesenchymal Transition/Epithelial-Mesenchymal Transition/*genetics ; Fibroblast Growth Factor 2/Fibroblast Growth Factor 2/Fibroblast Growth Factor 2/*metabolism

  • Source: PloS one [PLoS One] 2015 Dec 09; Vol. 10 (12), pp. e0144073. Date of Electronic Publication: 2015 Dec 09 (Print Publication: 2015).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.

  • Authors : Xu B; Department of Urology, Nanjing Medical University, Nanjing, 210029, China.; Niu X

Subjects: Cell Proliferation*; Carcinoma/Carcinoma/Carcinoma/*pathology ; Cell Movement/Cell Movement/Cell Movement/*genetics

  • Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2011 Apr; Vol. 350 (1-2), pp. 207-13. Date of Electronic Publication: 2011 Jan 01.Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence.

  • Authors : Liu C; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Photothermal Therapy*/Photothermal Therapy*/Photothermal Therapy*/methods ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 May 03; Vol. 22 (1), pp. 224. Date of Electronic Publication: 2024 May 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

×
Academic Journal

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

  • Authors : Chen N; Department of Urology, Meizhou People's Hospital, Meizhou 514089, China.; Wang Z

Subjects: Goserelin*/Goserelin*/Goserelin*/adverse effects ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy; Male

  • Source: Cancer biology & medicine [Cancer Biol Med] 2024 Feb 05; Vol. 20 (12).Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer.

  • Authors : Wang J; Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, 832000, Xinjiang, China.; Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, 832000, Xinjiang, China.

Subjects: Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Animals

  • Source: BMC cancer [BMC Cancer] 2024 Jan 15; Vol. 24 (1), pp. 75. Date of Electronic Publication: 2024 Jan 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Chrysosplenol D can inhibit the growth of prostate cancer by inducing reactive oxygen species and autophagy.

  • Authors : Zhang H; Department of Urology, The Second People's Hospital of Kunshan, Kunshan, Jiangsu, China.; You Z

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Humans

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Oct; Vol. 11 (10), pp. e1061.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development of [ 177 Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.

  • Authors : Wen X; State Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of PublicHealth, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China.; Xu P

Subjects: Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism; Male

  • Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (9), pp. 2846-2860. Date of Electronic Publication: 2023 Apr 25.Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis.

  • Authors : Ye X; School of Medicine, Southern University of Science and Technology, No. 1088 Xue Yuan Blvd, Shenzhen, 518055, Guangdong, China.; Huang X

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/metabolism; Humans

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2023 May 03; Vol. 16 (1), pp. 46. Date of Electronic Publication: 2023 May 03.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

Record details

×
Academic Journal

miR-92a-1-5p enriched prostate cancer extracellular vesicles regulate osteoclast function via MAPK1 and FoxO1.

  • Authors : Yu L; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. .; Institute of Laboratory Medicine Center of Chinese People's Liberation Army (PLA), Xijing Hospital, Fourth Military Medical University (Air Force Medical University), , Xi'an, 710032, China. .

Subjects: Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/genetics ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 May 02; Vol. 42 (1), pp. 109. Date of Electronic Publication: 2023 May 02.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

×
  • 1-10 of  176 results for ""Zhang X""